| Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic M Sharifian-Dorche, P Huot, M Osherov, D Wen, A Saveriano, ... Journal of the neurological sciences 417, 117085, 2020 | 271 | 2020 |
| COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: a systematic review M Sharifian-Dorche, MA Sahraian, G Fadda, M Osherov, ... Multiple sclerosis and related disorders 50, 102800, 2021 | 79 | 2021 |
| Magnetic resonance brain imaging in patients with visual vertigo L Pollak, M Osherov, N Berkovitz, I Beckerman, R Stryjer, S Tal Brain and behavior 5 (11), e00402, 2015 | 24 | 2015 |
| Mycosis fungoides–A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis Z Nitsan, N Kucuk, S Appel, N Tichmanovich, M Osherov, R Milo Journal of Clinical Neuroscience 48, 102-103, 2018 | 11 | 2018 |
| Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course Z Nitsan, OS Cohen, J Chapman, E Kahana, AD Korczyn, S Appel, ... Journal of Neurology 267, 2455-2458, 2020 | 8 | 2020 |
| Daclizumab and its use in multiple sclerosis treatment R Milo, M Osherov Drugs Today (Barc) 53 (1), 7-18, 2017 | 6 | 2017 |
| In whom does horizontal canal BPPV recur? L Pollak, R Huna-Baron, M Osherov, M Roni American Journal of Otolaryngology 39 (4), 410-412, 2018 | 5 | 2018 |
| Association between cervical disc disease and lesions of multiple sclerosis M Alkrenawi, M Osherov, A Simonovich, J Droujin, R Milo, S Appel The neuroradiology journal 34 (3), 200-204, 2021 | 3 | 2021 |
| Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis M Osherov, R Milo Expert Review of Clinical Pharmacology 10 (10), 1037-1047, 2017 | 3 | 2017 |
| The consequences of switching from Gilenya® to generics for fingolimod L Menendez, M Osherov, Z Nitsan, M Alkrenawi, A Gelfand, N Hovel, ... Multiple Sclerosis and Related Disorders 74, 104692, 2023 | 2 | 2023 |
| Dual positivity for anti-mog and oligoclonal bands: Unveiling unique clinical profiles and implications E Ganelin-Cohen, S Shelly, Y Schiller, A Vaknin-Dembinsky, M Shachor, ... Multiple Sclerosis and Related Disorders 79, 105034, 2023 | 1 | 2023 |
| Cervical disc disease is not associated with demyelanting lesions in multiple sclerosis M Alkrenawi, S Appel, M Osherov, A Simonovich, J Droujin, R Milo MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 382-382, 2020 | | 2020 |
| B Cell-based Therapies for Multiple Sclerosis M Osherov, R Milo | | 2019 |
